Hopo Therapeutics, Inc.

Emeryville, CA Part of F Block Holdings LLC

UEI
H5MWN5ZBXQ98
CAGE
8L3L6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
5858 Horton St #393, Emeryville, CA 94608, USA
Website
hopotx.com
Founded
2020
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Hopo Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of hopo-101 as an MCM (medical countermeasure) decorporation agent for the treatment of individuals with… Contract · 75A50124C00062 Office of the Assistant Secretary for Preparedness and Response $14,209,253

Quick answers

What is Hopo Therapeutics, Inc.'s UEI?

Hopo Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is H5MWN5ZBXQ98.

What is Hopo Therapeutics, Inc.'s CAGE code?

Hopo Therapeutics, Inc.'s CAGE code is 8L3L6.

What is Hopo Therapeutics, Inc.'s primary NAICS code?

Hopo Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Hopo Therapeutics, Inc. located?

Hopo Therapeutics, Inc.'s physical address in SAM.gov is 5858 Horton St #393, Emeryville, CA 94608, USA.

Is Hopo Therapeutics, Inc. registered in SAM.gov?

Yes. Hopo Therapeutics, Inc.'s SAM.gov registration is active through June 17, 2027.

Who is Hopo Therapeutics, Inc.'s parent company?

Hopo Therapeutics, Inc. is part of F Block Holdings LLC.

What is Hopo Therapeutics, Inc.'s most recent federal award?

Hopo Therapeutics, Inc.'s most recent federal contract award is Development of hopo-101 as an MCM (medical countermeasure) decorporation agent for the treatment of individuals with… (75A50124C00062), from Office of the Assistant Secretary for Preparedness and Response, on September 30, 2024.

On GovTribe

See Hopo Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors